These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9778042)

  • 1. Sulindac sulfide inhibits Ras signaling.
    Herrmann C; Block C; Geisen C; Haas K; Weber C; Winde G; Möröy T; Müller O
    Oncogene; 1998 Oct; 17(14):1769-76. PubMed ID: 9778042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway.
    Waldmann H; Karaguni IM; Carpintero M; Gourzoulidou E; Herrmann C; Brockmann C; Oschkinat H; Müller O
    Angew Chem Int Ed Engl; 2004 Jan; 43(4):454-8. PubMed ID: 14735533
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of cell transformation by sulindac sulfide is confined to specific oncogenic pathways.
    Gala M; Sun R; Yang VW
    Cancer Lett; 2002 Jan; 175(1):89-94. PubMed ID: 11734340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new sulindac derivative IND 12 reverses Ras-induced cell transformation.
    Karaguni IM; Herter P; Debruyne P; Chtarbova S; Kasprzynski A; Herbrand U; Ahmadian MR; Glüsenkamp KH; Winde G; Mareel M; Möröy T; Müller O
    Cancer Res; 2002 Mar; 62(6):1718-23. PubMed ID: 11912145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
    Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential targeting of protein kinase B in cell death induced by sulindac and its metabolite sulindac sulfide.
    Marotta A; Parhar K; Hundal R; Duronio V; Salh B
    Int J Oncol; 2006 Jun; 28(6):1471-9. PubMed ID: 16685448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does p21ras transform cells?
    Marshall CJ
    Trends Genet; 1991 Mar; 7(3):91-5. PubMed ID: 2031288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
    Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New indene-derivatives with anti-proliferative properties.
    Karaguni IM; Glüsenkamp KH; Langerak A; Geisen C; Ullrich V; Winde G; Möröy T; Müller O
    Bioorg Med Chem Lett; 2002 Feb; 12(4):709-13. PubMed ID: 11844707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis.
    Lim SJ; Lee E; Lee EH; Kim SY; Cha JH; Choi H; Park W; Choi HK; Ko SH; Kim SH
    Oncol Rep; 2012 Jun; 27(6):2023-30. PubMed ID: 22395735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.
    Shiff SJ; Qiao L; Tsai LL; Rigas B
    J Clin Invest; 1995 Jul; 96(1):491-503. PubMed ID: 7615821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
    Huang Y; He Q; Hillman MJ; Rong R; Sheikh MS
    Cancer Res; 2001 Sep; 61(18):6918-24. PubMed ID: 11559570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras regulatory interactions: novel targets for anti-cancer intervention?
    Prendergast GC; Gibbs JB
    Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by sulindac sulfide in HL60 cells is enhanced by p21CiP1 or p27KiP1.
    Ikui AE; Yao Y; Zhou P; Weinstein IB
    Anticancer Res; 2001; 21(4A):2297-303. PubMed ID: 11724286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of sulindac-induced apoptosis and cell cycle arrest.
    Jung B; Barbier V; Brickner H; Welsh J; Fotedar A; McClelland M
    Cancer Lett; 2005 Feb; 219(1):15-25. PubMed ID: 15694660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.